Wang T, Ge Z, Wu J, Li B, Liang A
Analytical Research Department, Merck Research Laboratories, Rahway, NJ 07065-0900, USA.
J Pharm Biomed Anal. 1999 May;19(6):937-43. doi: 10.1016/s0731-7085(98)00259-3.
A quick and sensitive method has been developed and validated for the determination of tungsten in bulk drug substance and intermediates using either Inductively Coupled Plasma Atomic Emission Spectrometry (ICP-AES) or Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Sample preparation is by direct dissolution with a 80:20 (v/v) concentrated nitric acid:deionized water mixture and avoids labor intensive and potentially hazardous digestion techniques. Excellent agreement was found between ICP-AES and ICP-MS results and between Merck results and Microwave Induced Plasma Mass Spectrometry (MIP-MS) results provided by an independent raw material vendor.
已开发并验证了一种快速灵敏的方法,用于使用电感耦合等离子体原子发射光谱法(ICP-AES)或电感耦合等离子体质谱法(ICP-MS)测定原料药和中间体中的钨。样品制备是通过用80:20(v/v)浓硝酸:去离子水混合物直接溶解,避免了劳动强度大且有潜在危险的消解技术。在ICP-AES和ICP-MS结果之间以及默克公司结果与独立原材料供应商提供的微波诱导等离子体质谱法(MIP-MS)结果之间发现了极好的一致性。